These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22361079)

  • 21. Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure.
    Nymo SH; Aukrust P; Kjekshus J; McMurray JJ; Cleland JG; Wikstrand J; Muntendam P; Wienhues-Thelen U; Latini R; Askevold ET; Gravning J; Dahl CP; Broch K; Yndestad A; Gullestad L; Ueland T;
    JACC Heart Fail; 2017 Apr; 5(4):256-264. PubMed ID: 28359413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure.
    Richter B; Koller L; Hohensinner PJ; Zorn G; Brekalo M; Berger R; Mörtl D; Maurer G; Pacher R; Huber K; Wojta J; Hülsmann M; Niessner A
    Int J Cardiol; 2013 Sep; 168(2):1251-7. PubMed ID: 23218577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proenkephalin and prognosis after acute myocardial infarction.
    Ng LL; Sandhu JK; Narayan H; Quinn PA; Squire IB; Davies JE; Bergmann A; Maisel A; Jones DJ
    J Am Coll Cardiol; 2014 Jan; 63(3):280-9. PubMed ID: 24140658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging.
    Ketchum ES; Jacobson AF; Caldwell JH; Senior R; Cerqueira MD; Thomas GS; Agostini D; Narula J; Levy WC
    J Nucl Cardiol; 2012 Oct; 19(5):1007-16. PubMed ID: 22949270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis.
    Aimo A; Januzzi JL; Vergaro G; Ripoli A; Latini R; Masson S; Magnoli M; Anand IS; Cohn JN; Tavazzi L; Tognoni G; Gravning J; Ueland T; Nymo SH; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; de Boer RA; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Tentzeris I; Tang WHW; Grodin J; Passino C; Emdin M
    Circulation; 2018 Jan; 137(3):286-297. PubMed ID: 29335288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure.
    Kuramoto Y; Yamada T; Tamaki S; Okuyama Y; Morita T; Furukawa Y; Tanaka K; Iwasaki Y; Yasui T; Ueda H; Okada T; Kawasaki M; Levy WC; Komuro I; Fukunami M
    Am J Cardiol; 2011 Apr; 107(8):1185-90. PubMed ID: 21349482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure.
    Demissei BG; Postmus D; Cleland JG; O'Connor CM; Metra M; Ponikowski P; Teerlink JR; Cotter G; Davison BA; Givertz MM; Bloomfield DM; van Veldhuisen DJ; Dittrich HC; Hillege HL; Voors AA
    Eur J Heart Fail; 2017 Jun; 19(6):728-738. PubMed ID: 28251755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Value of Galectin-3 for Adverse Outcomes in Chronic Heart Failure.
    French B; Wang L; Ky B; Brandimarto J; Basuray A; Fang JC; Sweitzer NK; Cappola TP
    J Card Fail; 2016 Apr; 22(4):256-62. PubMed ID: 26571149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Von Willebrand factor improves risk prediction in addition to N-terminal pro-B-type natriuretic peptide in patients referred to coronary angiography and signs and symptoms of heart failure and preserved ejection fraction.
    Kleber ME; Koller L; Goliasch G; Sulzgruber P; Scharnagl H; Silbernagel G; Grammer TB; Delgado G; Tomaschitz A; Pilz S; März W; Niessner A
    Circ Heart Fail; 2015 Jan; 8(1):25-32. PubMed ID: 25342739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple biomarkers for the prediction of first major cardiovascular events and death.
    Wang TJ; Gona P; Larson MG; Tofler GH; Levy D; Newton-Cheh C; Jacques PF; Rifai N; Selhub J; Robins SJ; Benjamin EJ; D'Agostino RB; Vasan RS
    N Engl J Med; 2006 Dec; 355(25):2631-9. PubMed ID: 17182988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of the addition of peak oxygen consumption to the Seattle Heart Failure Model in a transplant referral population.
    Levy WC; Aaronson KD; Dardas TF; Williams P; Haythe J; Mancini D
    J Heart Lung Transplant; 2012 Aug; 31(8):817-24. PubMed ID: 22759798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of risk indices in continuous-flow left ventricular assist device patients.
    Schaffer JM; Allen JG; Weiss ES; Patel ND; Russell SD; Shah AS; Conte JV
    Ann Thorac Surg; 2009 Dec; 88(6):1889-96. PubMed ID: 19932256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure.
    Pascual-Figal DA; Manzano-Fernández S; Boronat M; Casas T; Garrido IP; Bonaque JC; Pastor-Perez F; Valdés M; Januzzi JL
    Eur J Heart Fail; 2011 Jul; 13(7):718-25. PubMed ID: 21551163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.
    Ordu S; Ozhan H; Alemdar R; Aydin M; Caglar O; Yuksel H; Kandis H
    Tex Heart Inst J; 2012; 39(1):30-5. PubMed ID: 22412224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High serum level of pentosidine, an advanced glycation end product (AGE), is a risk factor of patients with heart failure.
    Koyama Y; Takeishi Y; Arimoto T; Niizeki T; Shishido T; Takahashi H; Nozaki N; Hirono O; Tsunoda Y; Nitobe J; Watanabe T; Kubota I
    J Card Fail; 2007 Apr; 13(3):199-206. PubMed ID: 17448417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarker predictors of cardiac hospitalization in chronic heart failure: a recurrent event analysis.
    Vorovich E; French B; Ky B; Goldberg L; Fang JC; Sweitzer NK; Cappola TP
    J Card Fail; 2014 Aug; 20(8):569-76. PubMed ID: 24929121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth differentiation factor 15 in heart failure with preserved vs. reduced ejection fraction.
    Chan MM; Santhanakrishnan R; Chong JP; Chen Z; Tai BC; Liew OW; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong RC; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2016 Jan; 18(1):81-8. PubMed ID: 26497848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score.
    Raposeiras-Roubín S; Rodiño-Janeiro BK; Grigorian-Shamagian L; Moure-González M; Seoane-Blanco A; Varela-Román A; Almenar-Bonet L; Alvarez E; González-Juanatey JR
    Am J Cardiol; 2011 Mar; 107(6):938-44. PubMed ID: 21247530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure.
    Zairis MN; Tsiaousis GZ; Georgilas AT; Makrygiannis SS; Adamopoulou EN; Handanis SM; Batika PC; Prekates AA; Velissaris D; Kouris NT; Mytas DZ; Babalis DK; Karidis KS; Foussas SG
    Int J Cardiol; 2010 Jun; 141(3):284-90. PubMed ID: 19157603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic utility of the Seattle Heart Failure Score and amino terminal pro B-type natriuretic peptide in varying stages of systolic heart failure.
    Adlbrecht C; Hülsmann M; Neuhold S; Strunk G; Pacher R
    J Heart Lung Transplant; 2013 May; 32(5):533-8. PubMed ID: 23453573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.